Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
45,818,944
-
Share change
-
+3,218,674
-
Total reported value
-
$447,595,905
-
Put/Call ratio
-
14%
-
Price per share
-
$9.77
-
Number of holders
-
132
-
Value change
-
-$376,588,200
-
Number of buys
-
79
-
Number of sells
-
77
Institutional Holders of DECIPHERA PHARMACEUTICALS IN - COM (DCPH) as of Q4 2021
As of 31 Dec 2021,
DECIPHERA PHARMACEUTICALS IN - COM (DCPH) was held by
132 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,818,944 shares.
The largest 10 holders included
STATE STREET CORP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BlackRock Inc., GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, BANK OF AMERICA CORP /DE/, New Leaf Venture Partners, L.L.C., CANADA PENSION PLAN INVESTMENT BOARD, and FEDERATED HERMES, INC..
This page lists
132
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.